Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01733875 · ClinicalTrials.gov registry record · Phase 1

2-part Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of CC-220 & Effect of Food on CC-220 in Healthy Subjects

A Phase 1 study of Healthy, sponsored by Celgene.

Completed
Registry status
Phase 1
Development phase
65
Enrollment target
1
Study location

NCT01733875 is a Phase 1 study of Healthy that has completed, run by Celgene. The registered enrollment target is 65 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01733875, a Phase 1 study of Healthy, has completed, sponsored by Celgene.

COMPLETED
Registry status
Phase 1
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single oral dose of CC-220 and to explore the effect of food on the bioavailability of CC-220 in healthy subjects

Conditions Studied

Healthy

Interventions

  • DRUG CC-220 0.03 mg
  • DRUG CC-220 0.1 mg
  • DRUG CC-220 0.3 mg
  • DRUG CC-220 1 mg
  • DRUG CC-220 2 mg

Study Locations (1)

Wisconsin

  • Covance Clinical Research Unit - Madison

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2012-11-01
Est. Completion 2013-10-09
Phase Phase 1

Sponsor

Celgene

308 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01733875

The ClinicalTrials.gov registry entry for NCT01733875 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (90% lower). The listed sponsor is Celgene, which has 308 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 5 interventions - of which CC-220 0.03 mg is the first listed.

NCT01733875 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT01733875 about?

NCT01733875 is a clinical study titled "2-part Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of CC-220 & Effect of Food on CC-220 in Healthy Subjects". To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single oral dose of CC-220 and to explore the effect of food on the bioavailability of CC-220 in healthy subjects

What is the current status of trial NCT01733875?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 65 participants. The study started on 2012-11-01. Estimated completion is 2013-10-09.

What conditions does trial NCT01733875 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT01733875?

The interventions under investigation include: CC-220 0.03 mg (DRUG), CC-220 0.1 mg (DRUG), CC-220 0.3 mg (DRUG), CC-220 1 mg (DRUG), CC-220 2 mg (DRUG).

Who is sponsoring clinical trial NCT01733875?

This trial is sponsored by Celgene, which has 308 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01733875 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Wisconsin

All trials with a study site in Wisconsin

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.